Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Presbyterian Hospital located at 1100 Central Se, Albuquerque, NM, 87106 & includes data from NPIs 1215913470
Dexur analyzed Q2 2017 (April to June 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Presbyterian Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,266 | 2,161 | ||||||||||
| Surgical | 722 | 706 | ||||||||||
| Non Surgical | 1,544 | 1,455 | ||||||||||
| General Medicine | 441 | 402 | ||||||||||
| Cardiovascular | 385 | 369 | ||||||||||
| Orthopedics | 378 | 374 | ||||||||||
| Gastroenterology & Endocrinology | 231 | 220 | ||||||||||
| Pulmonology | 230 | 222 | ||||||||||
| General Surgery | 158 | 151 | ||||||||||
| Urology | 149 | 148 | ||||||||||
| Neurology | 128 | 119 | ||||||||||
| Oncology & Hematology | 87 | 82 | ||||||||||
| Colorectal | 29 | 27 | ||||||||||
| Obstetrics & Gynecology | 16 | 15 | ||||||||||
| Psychiatry & Mental Disorders | 14 | 12 | ||||||||||
| Spine | 12 | 12 |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peptic Ulcer | ||||||||||||
| Poisoning And Toxic Effects Of Drugs |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Endovascular Procedures | ||||||||||||
| Hypertension |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Cholecystectomy | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Other Digestive System Diagnoses |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| Respiratory Infections And Inflammations |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Other Respiratory System O.R. Procedures |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Seizures |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Digestive Malignancy |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Mexico Total Hospitalizations (Apr 2017 to Jun 2017) | New Mexico Total Hospitalizations After Exclusion | New Mexico Total Users | New Mexico SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcohol/Drug Abuse Or Dependence |